-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bmxzuosm4EAWN1YrLXcE+Fe9QizKiB7nJ+Q0DlUJlpeDoWaeyTTzUXuJFzA2QoPz pvVzPkzUWxYsrblIKVyF+w== 0001181431-04-054050.txt : 20041118 0001181431-04-054050.hdr.sgml : 20041118 20041118183637 ACCESSION NUMBER: 0001181431-04-054050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041118 FILED AS OF DATE: 20041118 DATE AS OF CHANGE: 20041118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON LIFE SCIENCES INC /DE CENTRAL INDEX KEY: 0000094784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870277826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 137 NEWBURY STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174250200 MAIL ADDRESS: STREET 1: 137 NEWBURY STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: GREENWICH PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: STRATEGIC MEDICAL RESEARCH CORP /DE DATE OF NAME CHANGE: 19790521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYKETT MARK JEROME CENTRAL INDEX KEY: 0001278271 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-06533 FILM NUMBER: 041156006 BUSINESS ADDRESS: STREET 1: ADVENTRX STREET 2: 9948 HILBERT ST CITY: SAN DIEGO STATE: CA ZIP: 92131 BUSINESS PHONE: 978 561 1119 MAIL ADDRESS: STREET 1: 223A MAIN ST CITY: BOXFORD STATE: MA ZIP: 021921 4 1 rrd56364.xml FORM 4 X0202 4 2004-11-18 0 0000094784 BOSTON LIFE SCIENCES INC /DE BLSI 0001278271 PYKETT MARK JEROME 20 NEWBURY STREET BOSTON MA 02116 0 1 0 0 EVP & Chief Operating Officer Employee Stock Option (Right to Buy) 0.75 2004-11-18 4 A 0 500000 0 A 2014-11-18 Common Stock 500000 500000 D The option was granted outside of the Company's stock option plans. The option is vested immediately as to 125,000 shares. The remainder will vest monthly in equal installments over the next four years. /s/ Mark Pykett 2004-11-18 -----END PRIVACY-ENHANCED MESSAGE-----